ロード中...

Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting

PURPOSE: Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence shows that PDGFR participates in the development and progression of cervical cancer. Although imatinib has exhibited preclinical activity against cervical cancer, only minimal clinical therapeutic efficacy was o...

詳細記述

保存先:
書誌詳細
主要な著者: Ye, Peng, Zhang, Wendian, Yang, Tan, Lu, Yao, Lu, Miao, Gai, Yongkang, Ma, Xiang, Xiang, Guangya
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019625/
https://ncbi.nlm.nih.gov/pubmed/24855354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S60178
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!